News Channels

21 Jul 2019 Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon™ CNP in Children with Achondroplasia
21 Jul 2019 PMZ-1620, an Endothelin-B Agonist, enters Phase III Trial in Patients with Cerebral Ischemic Stroke
21 Jul 2019 Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR
21 Jul 2019 FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
21 Jul 2019 Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of DARZALEX® (daratumumab)
21 Jul 2019 Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
19 Jul 2019 EMA Accepts Samsung Bioepis’ MAA for SB8 Bevacizumab Biosimilar Candidate
19 Jul 2019 Eisai Presented Data Showing Quantification of Tau Microtubule Binding Region at AAIC 2019
18 Jul 2019 MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi
18 Jul 2019 Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
18 Jul 2019 Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
18 Jul 2019 Transgene Receives MHRA Approval for a Clinical Trial of TG6002, a Next-generation Oncolytic Virus, Administered by Intrahepatic Artery Infusion in Patients with Colorectal Cancer with Liver Metastases
18 Jul 2019 MacroGenics Provides Update on Flotetuzumab Program in Acute Myeloid Leukemia
18 Jul 2019 Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
18 Jul 2019 Bayer, Bristol-Myers Squibb and Ono Pharmaceutical Enter Into a Clinical Collaboration Agreement to Investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as Combination Therapy in Patients With Metastatic Colorectal Cancer
18 Jul 2019 Sernova's Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data
18 Jul 2019 Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
18 Jul 2019 Zydus announces completion of enrollment in three Phase III trials of Saroglitazar Magnesium in NASH
18 Jul 2019 Eisai presents nonclinical research results of elenbecestat of without significant effects on synaptic function in brain by spinal densitiy evaluation at effective dose to decrease amyloid beta level in cerebrospinal fluid at AAIC 2019
17 Jul 2019 Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up